文献速递肿瘤 PET/CT

患者水化与强制利尿对[18F]PSMA-1007 PET/CT显像中膀胱摄取的影响

The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging.
PubMed 文献 · EJNMMI Res · 2025-06-19

这项前瞻性单中心研究纳入185例前列腺癌患者,分为无特殊准备的对照组(35例)和10个不同准备方案的实验组(每组15例),评估口服或静脉水化和/或呋塞米给药对[18F]PSMA-1007膀胱摄取的影响。结果显示呋塞米可显著降低膀胱LBM SUVmean的中位数和变异性(p<0.001),且PET扫描前30分钟给药优于90分钟(p<0.001);单纯水化不足以有效降低膀胱摄取(p=0.5)。

要点

  • 呋塞米强制利尿可显著降低[18F]PSMA-1007膀胱摄取的LBM SUVmean中位数和变异性(p<0.001)。
  • 呋塞米在PET扫描前30分钟给药较90分钟给药更优(p<0.001)。
  • 单纯水化而不使用呋塞米不足以有效降低膀胱LBM SUVmean的中位数和变异性(p=0.5)。

核心结论

  • 强制利尿是降低[18F]PSMA-1007膀胱摄取及其变异性的有效工具,适用于膀胱摄取常规增高的情况。

研究设计与样本

  • 前瞻性单中心研究纳入185例前列腺癌患者,均接受[18F]PSMA-1007 PET/CT,分为对照组(无特殊准备,n=35)和10个实验组(每组n=15),实验组采用不同的口服或静脉水化和/或呋塞米给药方案。
  • 以LBM SUVmean量化膀胱[18F]PSMA-1007摄取,比较各准备组间及与对照组的膀胱SUVmean差异,p<0.001视为有统计学意义,并通过四分位距(IQR)评估膀胱SUVmean的变异性。

主要发现

  • 应用呋塞米显著降低了膀胱LBM SUVmean的中位数和变异性(p<0.001)。
  • 呋塞米在PET扫描前30分钟给药优于90分钟给药(p<0.001)。
  • 单纯水化而不使用呋塞米不足以有效降低膀胱LBM SUVmean的中位数和变异性(p=0.5)。
  • 不同水化途径和容量组间无显著差异(p=0.03和0.45)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: [18F]PSMA-1007 has minimal renal excretion, allowing for better assessment of the pelvic area in patients with prostate cancer (PCa). Nevertheless, there have been instances of notably high [18F]PSMA-1007 uptake in the urinary bladder. The purpose of this study was to assess the impact of preliminary patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake. RESULTS: А prospective single-center study included 185 patients with PCa, who underwent [18F]PSMA-1007 PET/CT. Patients were divided into 11 groups: a control group with no specific preparation (n = 35) and 10 experimental groups (n = 15 in each) with different preparation protocols, that included oral or IV hydration and/or furosemide administration. LBM SUVmean was used to quantify [18F]PSMA-1007 bladder uptake. The differences in bladder SUVmean among the different preparation groups, as well as compared to the control group, were evaluated. A p-value < 0.001 was considered statistically significant. Additionally, the variability of bladder SUVmean was assessed by evaluating the interquartile ranges (IQRs). The results indicate that the application of furosemide significantly reduced the median and variability of bladder SUVmean (p < 0.001), 30 min time interval of furosemide application prior to PET scan is preferable compared to 90 min interval (p < 0.001). Hydration alone, without furosemide, was insufficient for effectively reducing the median and variability of bladder SUVmean (p = 0.5). There was no significant difference between the groups with different routes and volumes of hydration (p = 0.03 and 0.45). CONCLUSION: Forced diuresis is an effective tool for reducing the [18F]PSMA-1007 urinary bladder uptake and its variability when it is routinely increased. CLINICAL TRIAL NUMBER: Not applicable.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Khalimon AI, Nikiforuk AI, Khodzhibekova MM, et al. The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging. EJNMMI Res. 2025. PMID: 40537715. doi:10.1186/s13550-025-01271-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。